Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.
Dubois LJ, Lieuwes NG, Janssen MH, Peeters WJ, Windhorst AD, Walsh JC, Kolb HC, Ollers MC, Bussink J, van Dongen GA, van der Kogel A, Lambin P. Dubois LJ, et al. Among authors: van der kogel a, van dongen ga. Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14620-5. doi: 10.1073/pnas.1102526108. Epub 2011 Aug 23. Proc Natl Acad Sci U S A. 2011. PMID: 21873245 Free PMC article.
PET imaging of hypoxia using [18F]HX4: a phase I trial.
van Loon J, Janssen MH, Ollers M, Aerts HJ, Dubois L, Hochstenbag M, Dingemans AM, Lalisang R, Brans B, Windhorst B, van Dongen GA, Kolb H, Zhang J, De Ruysscher D, Lambin P. van Loon J, et al. Among authors: van dongen ga. Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1663-8. doi: 10.1007/s00259-010-1437-x. Epub 2010 Apr 6. Eur J Nucl Med Mol Imaging. 2010. PMID: 20369236 Clinical Trial.
PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Hoeben BA, Kaanders JH, Franssen GM, Troost EG, Rijken PF, Oosterwijk E, van Dongen GA, Oyen WJ, Boerman OC, Bussink J. Hoeben BA, et al. Among authors: van dongen ga. J Nucl Med. 2010 Jul;51(7):1076-83. doi: 10.2967/jnumed.109.073189. Epub 2010 Jun 16. J Nucl Med. 2010. PMID: 20554724 Free article.
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer.
Lambin P, Petit SF, Aerts HJ, van Elmpt WJ, Oberije CJ, Starmans MH, van Stiphout RG, van Dongen GA, Muylle K, Flamen P, Dekker AL, De Ruysscher D. Lambin P, et al. Among authors: van stiphout rg, van dongen ga, van elmpt wj. Radiother Oncol. 2010 Aug;96(2):145-52. doi: 10.1016/j.radonc.2010.07.001. Epub 2010 Jul 19. Radiother Oncol. 2010. PMID: 20647155
PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET.
Slobbe P, Poot AJ, Windhorst AD, van Dongen GA. Slobbe P, et al. Among authors: van dongen ga. Drug Discov Today. 2012 Nov;17(21-22):1175-87. doi: 10.1016/j.drudis.2012.06.016. Epub 2012 Jul 2. Drug Discov Today. 2012. PMID: 22766374 Review.
Imaging of TKI-target interactions for personalized cancer therapy.
Poot AJ, Slobbe P, Hendrikse NH, Windhorst AD, van Dongen GA. Poot AJ, et al. Among authors: van dongen ga. Clin Pharmacol Ther. 2013 Mar;93(3):239-41. doi: 10.1038/clpt.2012.242. Epub 2012 Dec 12. Clin Pharmacol Ther. 2013. PMID: 23340475 No abstract available.
Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
Slobbe P, Windhorst AD, Stigter-van Walsum M, Schuit RC, Smit EF, Niessen HG, Solca F, Stehle G, van Dongen GA, Poot AJ. Slobbe P, et al. Among authors: van dongen ga. Nucl Med Biol. 2014 Oct;41(9):749-57. doi: 10.1016/j.nucmedbio.2014.06.005. Epub 2014 Jun 25. Nucl Med Biol. 2014. PMID: 25066021
237 results